High expression of CX3CL1/CX3CR1 at the mother-fetus interface of preeclampsia inhibits trophoblast invasion and migration

被引:0
作者
Liu, Haixia [1 ,2 ,3 ,4 ]
Wang, Ping [1 ]
Yin, Junbin [5 ]
Yang, Ping [1 ]
Shi, Jingjing [1 ]
Li, Aihua [4 ]
Wang, Xietong [1 ,2 ,3 ]
Meng, Jinlai [1 ,2 ,3 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China
[2] Qingdao Univ, Key Lab Maternal & Fetal Med Natl Hlth Commiss Chi, Shandong Prov Maternal & Child Hlth Care Hosp, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China
[4] Liao Cheng Peoples Hosp, Dept Obstet & Gynecol, Liaocheng, Shandong, Peoples R China
[5] 960th Hosp PLA, Dept Neurol, Jinan, Shandong, Peoples R China
关键词
Preeclampsia; Fractalkine/CX3CL1; CX3CR1; Macrophage; VEGF; FAK; Pregnancy; ANGIOGENESIS; FRACTALKINE;
D O I
10.1016/j.placenta.2024.08.008
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Preeclampsia is associated with maternal inflammatory overreaction and imbalanced immunity at the mother-fetus interface. The pro-inflammatory chemokine fractalkine (CX3CL1) is recently recognized apart from imbalanced immunity. In this study, CX3CL1- CX3C chemokine receptor 1(CX3CR1) regulation of decidual macrophage function and trophoblast invasion ability in preeclampsia was initially explored. Methods: The study comprised 60 women allocated to NP group (normotensive pregnant woman, n = 30) and sPE group (woman with severe preeclampsia, n = 30). After the delivery, the expression of CX3CL1 in placental tissues of the two groups was detected by immunohistochemical analysis. The protein level of CX3CL1 in placental tissue and CX3CR1 in decidua tissue was detected by Western Blot and the localization of CX3CR1 expression in decidua was detected by immunofluorescence. Macrophages were polarized into classically activated (M1) macrophages. M1 were treat with PBS (control group), recombinant human CX3CL1 (CX3CL1 group), recombinant human CX3CL1+ selective CX3CR1 antagonist-JMS-17-2 (CX3CL1+anti-CX3CR1 group) and recombinant human CX3CL1 + selective CX3CR1 antagonist-JMS-17-2 + VS-6063 (CX3CL1+anti-CX3CR1+ FAK inhibitor group). M1 and HTR8/SVneo cells were co-cultured as described previously to assess invasion and migration capacity by transwell assays and Wound-healing assay. Results: In this study, CX3CL1 expression is high in the placental tissues of severe preeclampsia (sPE) patients than in normotensive pregnancies (NP). CX3CR1 expression is high in the decidual tissues of severe preeclampsia patients and mainly expressed in macrophages of decidual tissues. CX3CL1/CX3CR1 decreased VEGF expression in M1 macrophages and reduced the invasion and migration function of HTR-8/SVneo through the FAK signaling pathway. Discussion: These findings revealed that CX3CL1-CX3CR1 regulate the trophoblast function by FAK and provided new insights into the pathogenesis of preeclampsia.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 34 条
  • [1] Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy
    Abu El-Asrar, Ahmed M.
    Nawaz, Mohd Imtiaz
    Ahmad, Ajmal
    De Zutter, Alexandra
    Siddiquei, Mohammad Mairaj
    Blanter, Marfa
    Allegaert, Eef
    Gikandi, Priscilla W.
    De Hertogh, Gert
    Van Damme, Jo
    Opdenakker, Ghislain
    Struyf, Sofie
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [2] [Anonymous], 2020, Obstet Gynecol, V135, P1492, DOI [10.1097/AOG.0000000000003018, 10.1097/AOG.0000000000003892]
  • [3] Pre-eclampsia
    Chappell, Lucy C.
    Cluver, Catherine A.
    Kingdom, John
    Tong, Stephen
    [J]. LANCET, 2021, 398 (10297) : 341 - 354
  • [4] Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican, Sarah
    Griffin, Matthew D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Immunology of the Maternal-Fetal Interface
    Erlebacher, Adrian
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 : 387 - 411
  • [6] Gatford KL, 2020, HYPERTENSION, V75, P1363, DOI [10.1161/HYPERTENSIONAHA.119.14598.), 10.1161/HYPERTENSIONAHA.119.14598]
  • [7] Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications
    Guo, Xi
    Yi, Hong
    Li, Tin Chiu
    Wang, Yu
    Wang, Huilin
    Chen, Xiaoyan
    [J]. BIOMOLECULES, 2021, 11 (02) : 1 - 16
  • [8] Regulation of CX3CL1 Expression in Human First-Trimester Decidual Cells: Implications for Preeclampsia
    Huang, S. Joseph
    Chen, Chie-Pein
    Buchwalder, Lynn
    Yu, Ya-Chun
    Piao, Longzhu
    Huang, Chun-Yen
    Schatz, Frederick
    Lockwood, Charles J.
    [J]. REPRODUCTIVE SCIENCES, 2019, 26 (09) : 1256 - 1265
  • [9] Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro
    Ilic, D
    Genbacev, O
    Jin, F
    Caceres, E
    Almeida, EAC
    Bellingard-Dubouchaud, V
    Schaefer, EM
    Damsky, CH
    Fisher, SJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) : 93 - 108
  • [10] Therapeutic intervention of inflammatory/ immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
    Imai T.
    Yasuda N.
    [J]. Inflammation and Regeneration, 36 (1)